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Abstract
It has been reported that IL-6 knockout mice (IL-62/2) possess lower endurance capacity than wild type mice (WT), however
the underlying mechanism is poorly understood. The aim of the present work was to examine whether reduced endurance
running capacity in IL-62/2 mice is linked to impaired maximal oxygen uptake (V9O2max), decreased glucose tolerance,
endothelial dysfunction or other mechanisms. Maximal running velocity during incremental running to exhaustion was
significantly lower in IL-62/2 mice than in WT mice (13.0060.97 m.min21 vs. 16.8961.15 m.min21, P,0.02, respectively).
Moreover, the time to exhaustion during running at 12 m.min21 in IL-62/2 mice was significantly shorter (P,0.05) than in
WT mice. V9O2max in IL-6
2/2 (n = 20) amounting to 108.362.8 ml.kg21.min21 was similar as in WT mice (n = 22) amounting
to 113.061.8 ml.kg21.min21, (P = 0.16). No difference in maximal COX activity between the IL-62/2 and WT mice in m. soleus
and m. gastrocnemius was found. Moreover, no impairment of peripheral endothelial function or glucose tolerance was
found in IL-62/2 mice. Surprisingly, plasma lactate concentration during running at 8 m.min21 as well at maximal running
velocity in IL-62/2 mice was significantly lower (P,0.01) than in WT mice. Interestingly, IL-62/2 mice displayed important
adaptive mechanisms including significantly lower oxygen cost of running at a given speed accompanied by lower
expression of sarcoplasmic reticulum Ca2+-ATPase and lower plasma lactate concentrations during running at submaximal
and maximal running velocities. In conclusion, impaired endurance running capacity in IL-62/2 mice could not be explained
by reduced V9O2max, endothelial dysfunction or impaired muscle oxidative capacity. Therefore, our results indicate that IL-6
cannot be regarded as a major regulator of exercise capacity but rather as a modulator of endurance performance.
Furthermore, we identified important compensatory mechanism limiting reduced exercise performance in IL-62/2 mice.
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Introduction
It is widely recognized that interleukins are secreted by
macrophages and lymphocytes to coordinate the response of the
immune system to injury and infection [1]. Although interleukin-6
(IL-6) is known as a key modulator of this response [2], it is also
considered as an ‘‘exercise factor’’ released by contracting skeletal
muscles into the circulation which adjusts substrate (lipid and
carbohydrate) metabolism to increased energy demand during
exercise [3,4]. Depending on the exercise intensity and its
duration, plasma level of IL-6 in humans can be elevated even
up to 100-fold after long lasting exercise (e.g. marathon run) and
drops to its basal soon after the exercise is terminated [5]. IL-6
exerts its effects both on the whole body and skeletal muscles via
endocrine and paracrine/autocrine manners, respectively, without
activating classical pro-inflammatory pathways [6]. Namely, it has
been postulated that IL-6 stimulates hepatic glucose release and
lipolysis in adipose tissue as well as glucose uptake and fatty acid
oxidation in skeletal muscles thus providing contracting skeletal
muscle fibres with energetic substrates [4]. Since IL-6 is considered
to be vital for regulation of glucose and lipid metabolism during
exercise, its deficiency should lead to the impairment of exercise
performance. Indeed, it was consistently reported that IL-6
knockout mice displayed compromised treadmill and swimming
exercise capacity as evidenced by their reduced endurance time
[7–9]. However, the data concerning regulation of the whole-body
glucose and lipid metabolism in IL-62/2 animals are not so
evident since one group referred to age-related insulin resistance
and weight gain of IL-62/2 mice [10,11] while the other did not
confirm this observation [12,13]. Therefore, these data cannot
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explain the reduced exercise performance of IL-62/2 mice. It
seems that, despite previous works, the mechanisms underlying
impairment of exercise tolerance in IL-62/2 animals are still not
known.
It has been also reported that, in spite of lower exercise
tolerance of the IL-62/2 mice, their oxygen cost of running during
exercise at submaximal intensities is significantly lower than in
WT mice for unknown reason [7]. Fäldt et al. [7] postulated that it
could be due to progressive oxygen depletion in these animals. If
indeed it would be the case, the maximal oxygen uptake (V9O2max)
in IL-62/2 mice should be significantly lower than in the WT
mice. In the present study we have hypothesized that lower
exercise tolerance in the IL-62/2 mice will be accompanied by
lower V9O2max. We also examined whether lower exercise
tolerance in IL-62/2 could be linked to alterations in glucose
tolerance, endothelial function or changes in locomotor muscle
profile including activities of mitochondrial enzymes or expression




The experiment protocol was approved by the Bioethics
Committee of Institute of Pharmacology, Polish Academy of
Sciences, Krakow, Poland (Permit Number: 914/2012). All
experiments including treadmill exercise were preceded with
acclimatization time to minimize stress of animals whereas surgery
procedures were carried out under ketamine/xylazine anesthesia.
Eighty nine male IL-62/2 mice and their age-matched wild
type IL+/+ (WT) littermates used as controls in all experiments
were bred in Medical University of Bialystok, Poland. The animals
were between 7 and 10-month-old once they were enrolled into
the study and since then they were housed in single cages. They
were maintained on a 12:12 h light-dark cycle and were given
unlimited access to food and water for the duration of the
experiment. At the end of the experiment, lack of functional IL-6
gene was confirmed by genotyping of liver samples. Namely,
genomic DNA was isolated with Genomic Mini kit (A&A
Biotechnology, Gdansk, Poland) and PCR was performed using
DreamTaq Green PCR Master Mix (ThermoScientific, Rockford,
IL) and specific primers (M_IL-6_Fwd 59-CCATC-
CAGTTGCCTTCTTG-3 and M_Il-6_Rev 59-AAGTGCAT-
CATCGTTGTTCATAC-39). Subsequently, DNA was separated
by electrophoresis on the agarose gel with ethidium bromide and
liver samples of IL-6 knockouts were distinguished from WT
control animals on the basis of their size (2400 bp for IL-62/2 and
1476 bp for WT mice).
Exercise capacity and endurance training protocols
WT and IL-62/2 mice were acclimatized to the motorized
treadmills (closed one-lane treadmill for whole body gas exchange
measurements and six-lane treadmill for the assessment of running
performance capacities) (Columbus Instruments, Columbus, OH,
USA) for three weeks. Subsequently, we assessed exercise capacity
of both WT control as well as IL-62/2 knockout animals by
measuring their (1) maximal oxygen consumption (V9O2max)
during maximal incremental test, (2) oxygen consumption (V9O2)
at maximal running velocity (vmax) (V9O2 at vmax) and (3)
endurance time (the duration of run until exhaustion at the given
speed). For estimation of the V9O2 during incremental test, each
mouse was placed on the closed treadmill at 0u incline equipped
with oxygen and carbon dioxide sensors to measure the
concentration of the gases in the outflowing air using the
Columbus Instruments’ Comprehensive Lab Animal Monitoring
System (CLAMS, Columbus Instruments, Columbus, OH, USA).
Once the animal was acclimatized to the treadmill and its oxygen
consumption became stable, the treadmill was started at
5 m.min21 and the speed was incrementally increased by
4 m.min21 every 3 min until the mouse reached exhaustion
defined as being unable to continue running for at least 5 s in spite
of the electric stimulus. To minimize effects of any errors resulting
with poor repeatability of forced exercise endurance tests for the
particular rodent subjects reported by Knab et al. [14], each
mouse performed this test twice with one-week interval in between
and the higher V9O2max/vmax values of the two obtained were
considered as the ‘‘true’’ V9O2max/vmax for the particular animal.
Endurance time was assessed on the six-lane treadmill at the 0u
incline at running velocities of 10 and 12 m . min21 constituting,
respectively, ,77% and ,95% of vmax of IL-6 knockout mice.
After acclimatization to the treadmill and warm up at 5 m.min21,
animals were forced to run at 10 m.min21 until exhaustion
(defined as above) but no longer than 2 hrs. For estimation of their
endurance time at 12 m.min21, they warmed up at 5 and
10 m.min21 and then were forced to run at 12 m.min21 until
exhaustion but not longer than 1 h. It is worth mentioning that
both groups of mice were kept in the same conditions (same size of
cages) through their life, thus the IL-62/2 mice and WT mice
were similarly exposed to physical activity. Therefore, any
differences among them concerning their physical capacity could
not be attributable to the differences in their training background
but only to the presence or lack of IL-6-dependent activity.
Monitoring of the oxygen consumption
For estimation of basal oxygen consumption (basal V9O2) and
V9O2 during sub-maximal exercise, mice were acclimatized to the
closed metabolic cage or closed one-lane treadmill equipped with
oxygen and carbon dioxide sensors (Columbus Instruments,
Columbus, OH, USA) for a week. The basal oxygen consumption
(basal V9O2) was measured at a set time of the day (7–9 a.m.) for
1 h following 30 min of an animal acclimatization. To determine
their V9O2 during sub-maximal exercise, mice were run at
6 m.min21 for 1 hour.
Temperature measurements
Body temperature at rest was assessed rectally around 9 a.m.
after measurement of basal V9O2 (see above) whereas body
temperature after sub-maximal exercise was measured before and
immediately after animals completed 1-hour run at 8 m.min21
around 9 a.m.
Glucose tolerance test
Glucose tolerance was assessed in mice at the age of 10 and 12
months. Mice were starved for 18 hrs and, then their basal glucose
concentration was measured in blood samples obtained from the
tail vein and diluted with saline (ABX Pentra 400 biochemical
analyser, Horiba ABX, France). Subsequently, mice were intra-
peritoneally injected with glucose (2 g.kg21) and glucose concen-
tration was measured at 15, 30, 45, 60 and 120 min time points.
Tissue samples collection
Mice were anesthetized with ketamine and xylazine (100 and
10 mg.kg21, respectively). Subsequently, aorta, liver and skeletal
muscles (soleus and gastrocnemius) were harvested and snap-frozen in
liquid nitrogen for further analysis except from aorta that was
placed on Krebs buffer (118.06 mM NaCl, 4.69 mM KCl,
1.19 mM KH2PO4, 1.16 mM MgSO4, 2.52 mM CaCl2, 25 mM
Preserved V9O2max in the IL-6
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NaHCO3, 10 mM glucose, 2 mM pyruvic acid sodium,
0.030 mM EDTA), cleaned from the connective and adventitia
tissues and cut into 2-mm rings. Aortic rings were subsequently
mounted in Multi Wire Myograph System (620M, DMT,
Denmark) and maintained in KH buffer at 37uC equilibrated
with 95%O2-5%CO2 to measure acetylcholine (ACh)- and sodium
nitroprusside (SNP)-dependent endothelial function. For determi-
nation of post-exercise plasma lactate concentration, separate
groups of IL-62/2 (n = 22) and WT animals (n = 22) were
subjected to either a single bout of submaximal exercise
(8 m.min21 for 1 hour) or incremental test (as described above)
and just after the run were sacrificed and their blood samples were
collected. After centrifugation, plasma lactate concentration was
determined with Stat Profile pHOx (Nova Biomedical, Waltham,
MA).
The blood variables and plasma lipid profile
Blood samples were collected in tubes containing EDTA and
were used either to perform the blood count (animal blood counter
Vet abc, Horiba Medical, France) or centrifuged to obtain plasma
which was further aliquoted and stored at 280uC for determina-
tion of lipid profile at ABX Pentra 400 biochemical analyzer
(Horiba ABX, France).
Cytochrome C oxidase (COX) and citrate synthase (CS)
activities
Skeletal muscle samples (soleus and mixed gastrocnemius) were
homogenized in the buffer containing 5 mM HEPES, 1 mM
EGTA, 0.1% Triton X-100, 1 mM DTT and 10 N KOH. COX
activity was measured as a time-course increase in absorbance at
550 nm due to oxidation of its substrate 1 mM reduced cytochrome
C from horse (Sigma Aldrich, St. Louis, MO) according to the
equation: reduced Cyt C+O2Roxidized Cyt C+H2O. CS activity
was determined as the increase of absorbance at 412 nm according
to reactions: acetylCoA (0.3 mM)+oxalacetic acid (0.5 mM)+H2OR
citrate acid+CoASH+DTNB (0.1 M)RCoAS+H+ +C6O4S22 (all
reagents were from Sigma Aldrich, St. Louis, MO). Subsequently,
enzyme activities were normalized to protein concentration in the
samples (measured with BCA assay) and the values were used to
calculate COX and CS activities.
Western blot
Skeletal muscles of non-exercising mice were homogenized in
the buffer containing protease and phosphatase inhibitors (In-
vitrogen Corp., Camarillo, CA). The protein concentration was
determined by BCA Protein Assay Kit (Thermo Scientific,
Rockford, IL). Subsequently, equal amounts of protein were
separated by SDS-PAGE, transferred to nitrocellulose membrane
and blocked with 5% non-fat dry milk/TBS-0.05% Tween
solution. The washed blots were incubated with primary
antibodies at following concentrations: anti-UCP3 (1 ug.ml21,
ab3477), anti-SERCA1 ATPase (1:1000, ab2819), anti-GAPDH
(1:10 000, ab8245). Upon washing in TBS-0.05% Tween, the
blots were incubated with goat anti-mouse polyclonal secondary
antibodies labelled with horseradish peroxidase (1:5000, ab6789).
Both the primary and secondary antibodies were from Abcam
(Cambridge, UK). The signal was detected with chemilumines-
cence detection kit (Bio-Rad Laboratories, Munich, Germany).
Statistical analysis
Statistical analysis was performed in GraphPad Prism5,
Statistica 10 and MS Excel 2003. P values lower than 0.05 were
considered significant. The details regarding the specific statistical
tests used are presented below relevant figures.
Results
Running performance during maximal incremental
exercise test in IL-6+/+ (WT) control and IL-6 knockout (IL-
62/2) mice
IL-62/2 and WT mice were subjected to maximal incremental
exercise treadmill test to assess their maximal running velocity in
this protocol (vmax) which was by about 23% lower for IL-6
knockouts (13.0060.97 m.min21, n = 12) when compared with
WT controls (16.961.2 m.min21, n = 12); P,0.02) (Figure 1A).
Therefore, running exercise performed at absolute intensities
determined by velocities of 10 and 12 m.min21 was more intense
for IL-62/2 than WT mice (Figures 1B and 1C). Simultaneously,
we also monitored oxygen consumption (V9O2) (Figure 1E) and
found that, in spite of no difference in maximal oxygen uptake
(V9O2max) between IL-6 knockouts (108.362.8 ml
.kg21.min21,
n = 20) and WT mice (113.061.8 ml.kg21.min21, n = 22;
P = 0.16) (Figure 1D), V9O2 of IL-6
2/2 animals at vmax was
lower (104.562.4 ml.kg21.min21, n = 21) when compared with
WT mice 111.061.7 ml.kg21.min21, n = 22; P,0.04) (Figure 1F).
When running at sub-maximal velocity of 6 m.min21 for 1 h, IL-
62/2 mice also displayed lower V9O2 when compared with WT
control mice (P,0.0001, F = 32.29, n = 6) (Figure 1G).
Running performance during prolonged exercise in
IL-6+/+ (WT) control and IL-6 knockout (IL-62/2) mice
It was previously reported that IL-62/2 mice displayed reduced
endurance time when compared with control animals [7–9]. Our
IL-62/2 mice forced to run for 2 hours at 10 m.min21 performed
as well as their WT littermates (Figure 2A) though this exercise was
more intense for them due to their lower maximal velocity
(Figure 1A). However, increasing the speed up to 12 m.min21
revealed compromised endurance time of IL-6 knockout animals
(Figure 2B). The discrepancy between these two speeds originated
from the fact that IL-62/2 mice during running at 12 m.min21
were actually exercising close to their maximal velocity
(1361 m.min21; Figure 1A) whereas the run at 10 m.min21
constituted only about 77% of their maximal running velocity
(vmax) established for each mouse during the incremental running
test (see Figure 1B).
Basal V9O2, blood count/plasma lipid profile, body
weight and temperature as well as glucose tolerance and
endothelial function of IL-6+/+ (WT) control and IL-6
knockout (IL-62/2) mice
To answer why IL-62/2 mice displayed reduced endurance
performance, we investigated the number of parameters that could
determine their exercise capacity. Contrary to V9O2 during
exercise, basal (resting) V9O2 of IL-6
2/2 mice was significantly
higher in comparison with WT control mice (P,0.0001, n = 10)
(Figure 3A), indicating their increased basal metabolism. The
blood count and plasma lipid profile were not different between
IL-62/2 and WT animals (Table 1). As it was reported that IL-
62/2 mice developed age-related obesity that might contribute to
their reduced exercise performance [7,11,15], we monitored their
body weight and found no difference (P.0.05) between IL-62/2
and WT mice both at the age of 10 and 12 months. Since reduced
exercise performance of IL-62/2 mice could also result from
increased energy dissipation, we measured their body temperature
which was not different both at rest (Figure 3C) and just after
Preserved V9O2max in the IL-6
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exercise (Figure 3D) between IL-62/2 and WT mice. Moreover,
our IL-62/2 mice also did not display an impaired glucose
tolerance either at 10 (Figure 3E) or 12 months of age (Figure 3F).
Subsequently, we investigated vasodilation response to acetylcho-
Figure 1. Running performance during maximal incremental exercise test in WT and IL-62/2 mice. Maximal velocity (vmax) (A), running
intensity at 10 m.min21 (B) and at 12 m.min21 (C), maximal oxygen consumption (V9O2max) (D), oxygen consumption during an incremental test with
increasing speeds (E), oxygen consumption at maximal velocity (V9O2 at vmax) (F) and oxygen consumption during 1-hour run at submaximal velocity
of 6 m.min21 (G). For determination of vmax (A), V9O2max (D) and V9O2 at vmax (F), WT control and IL-6
2/2 mice were run at an inclination of 0u with the
increasing speed and their oxygen consumption (V9O2) was registered (E) whereas for measurement of V9O2 during sub-maximal exercise, mice were
run at velocity of 6 m.min21 for 1 h (G). Data are presented as the mean 6 SEM. The symbols * denote values significantly different: *(P,0.05),
**(P,0.01), ***(P,0.001). Statistical analysis was performed in Statistica 10 (G; ANCOVA, n = 6, P,0.0001) or GraphPad Prism5 (two-sided T-test;
n = 22-11).
doi:10.1371/journal.pone.0088333.g001
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line (ACh) (eNOS dependent) and sodium nitroprusside (SNP)
(eNOS independent) of pre-constricted isolated aortic rings of
IL-62/2 and WT control animals (Figure 3G and 3H, respec-
tively) and found no impairment in ACh-induced vasodilation in
IL-62/2 vs WT mice (with SNP used as endothelium- indepen-
dent vasodilation control).
Cytochrome C oxidase (COX) and citrate synthase (CS)
activities in soleus and gastrocnemius skeletal muscles as
well as post-exercise plasma lactate in IL-6+/+ (WT)
control and IL-6 knockout (IL-62/2) mice
Because energy for endurance exercise is mainly provided by
oxidative phosphorylation, we measured COX and CS activities in
soleus (oxidative) and gastrocnemius (predominantly glycolytic)
skeletal muscles of IL-62/2 and WT control mice. There was
no significant difference in COX activity in soleus (oxidative)
muscle between IL-62/2 and WT controls (Figures 4A). Interest-
ingly, in this muscle we found that CS activity was significantly
higher for IL-62/2 mice (504629 U.g21, n = 10) than for WT
animals (37466 U.g21, P = 0.002, n = 8), (Figure 1C). For
predominantly glycolytic gastrocnemius, there was no difference in
COX and CS activities between IL-6 knockouts and WT controls
(Figures 4B, 4D) (probably because we did not distinguish between
the red (oxidative) and white (glycolytic) parts of this muscle).
Since also anaerobic (glycolytic) pathways can provide working
skeletal muscles with energy with lactate as a by-product, we
measured post-exercise plasma lactate concentration in IL-62/2
and WT mice subjected to a single bout of submaximal exercise
and found it lower by about 50% in IL-62/2
(5.2260.26 mmol.l21) when compared with WT control mice
(10.1360.25 mmol.l21), (n = 7–9, P,0.001) (Figure 4E). More-
over, maximal plasma lactate concentration determined after the
maximal incremental running test in the IL62/2 mice amounting
to 9.0361.79 mmol . l21 was significantly (P,0.01) lower in the
WT mice (amounting to 12.0362.27 mmol . l21) (Figure 4F).
Differences in skeletal muscle protein profile between
IL-6+/+ and IL-62/2 mice
As described above, IL-62/2 mice displayed increased CS but
not COX activities in oxidative soleus muscle in comparison with
WT control animals (Figures 4A and 4C). Moreover, IL-62/2
mice accumulated much less lactate in plasma during single-bout
exercise which might be due to lower muscle lactate production (as
described in Discussion section). These observations may indicate
energy deficiency in skeletal muscles of IL-62/2 mice which would
trigger compensatory mechanisms leading to reduction of energy
expenditure. Indeed, in soleus muscle of IL-62/2 mice we observed
decreased level of sarcoplasmic reticulum Ca2+-ATPase 1
(SERCA1) in IL-62/2 (115.168.4 a.u.) as compared to WT mice
(145.369.3 a.u., n = 7; P = 0.04) (Fig. 5A), that could indicate
reduction of energy expenditure whereas the level of UCP3
(participating in energy dissipation) was not altered (Fig. 5B). In
predominantly glycolytic gastrocnemius we did not detect any
changes in SERCA1 and UCP3 levels (Figures 5C and 5D).
Discussion
We designed this study to elucidate the mechanisms of reduced
endurance exercise capacity of IL-62/2 mice reported earlier [7–
9]. The main and original finding of this study is that our 10-
month old IL-62/2 mice displayed reduced exercise performance
as evidenced by their lower maximal running speed (by about
23%) obtained during maximal incremental test (Figure 1A) and
compromised endurance time while running on the treadmill at
running velocity of 12 m.min21 (Figure 2B), despite no difference
in V9O2max when compared to WT mice. Therefore, poorer
running capacity observed in these mice cannot be explained by
lower V9O2max, which in IL-6
2/2 mice was similar as in WT mice
(Figure 1D). It should be noted that in our study the impairment of
running capacity was evident only at high running velocities,
whereas during 2 h run at lower running velocities
(v = 10 m.min21), no difference in running performance between
IL-62/2 and WT mice was observed. These results are in
agreement with the finding by Benrick et al. [11] showing no
difference in endurance capacity between male IL-62/2 and WT
mice assessed during 50 minutes run at 75% of their V9O2max.
Taking into consideration the key role of V9O2max in determining
endurance exercise capacity, our results indicate that IL-6 cannot
be regarded as a major regulator of exercise capacity but rather as
a modulator of endurance performance.
It has been postulated that IL-6 might affect exercise tolerance
by its effect on AMP-activated protein kinase (AMPK) which is
considered as an energy sensor of the cell by monitoring the AMP
and ADP concentrations [16] and, thus, seems to play an
important role in maintaining energy homeostasis during exercise
(for review see [17]). It was demonstrated that elevated IL-6 levels
during exercise [4] positively correlated with an increase in AMPK
protein kinase activity [18] and, moreover, that AMPK could be
activated by increased levels of IL-6 [18,19]. On the contrary, lack
of IL-6 resulted in diminished AMPK activity both in sedentary
and exercised IL-62/2 mice [20]. Since it was shown that during a
Figure 2. Endurance time of WT mice and IL-62/2 mice. WT age-
matched littermates (–) and IL-62/2 mice (–) were run on the treadmill
at an inclination of 0u at either 10 (A) or 12 m.min21 (B) for 2 hrs or 1 h,
respectively, or until exhaustion as described in Materials and Methods.
The results were analyzed by the log-rank Mantel-Cox test in GraphPad
Prism 5 and only P values lower than 0.05 were considered significant
(n = 9–10).
doi:10.1371/journal.pone.0088333.g002
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single bout of exercise AMPK activation correlates positively with
eNOS phosphorylation in the mouse aorta [21] and that AMPK
co-immunoprecipitates with eNOS [22], we hypothesized that
impaired exercise capacity of IL-62/2 mice could be related to
Figure 3. Basal V9O2, body weight, temperature, glucose tolerance and endothelial function of WT and IL-6
2/2 mice. Basal oxygen
consumption (A), body weight (B), resting body temperature (C), increase in body temperature after exercise (D), glucose tolerance of 10 month old
mice (E), glucose tolerance of 12 month old mice (F), endothelium- dependent vasodilation of aortic rings (G), endothelium- independent
vasodilation of aortic rings (H). (A) Basal oxygen consumption was measured as described in Materials and Methods. Glucose tolerance (E,F) of WT and
IL-62/2 mice at 10 and 12 month of age were compared. Temperature at rest was measured around 9 a.m. for all animals (C). Subsequently, the
increase in body temperature after 1 hr run at 8 m.min21 of WT and IL-62/2 mice was compared (D). Peripheral endothelial function was assessed by
the measurements of acetylcholine (Ach)- induced vasodilation (G). Subsequently, endothelium-independent SNP-induced vasodilation of the same
aortic rings was record for comparison (H). Data are presented as the mean 6 SEM. Statistical analysis was performed in Statistica 10 (A; ANCOVA,
n = 10, P,0.0001) and in GraphPad Prism5 (two-sided T-test; n = 22–23 (B), n = 8–9 (C,D), n = 10–12 (E,F), n = 5 (G,H)).
doi:10.1371/journal.pone.0088333.g003
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endothelial dysfunction and compromised NO-dependent periph-
eral vasodilation that is a limiting factor of tissue perfusion during
exercise. Surprisingly, measurement of Ach-induced vasodilation
of pre-constricted aortic rings revealed no impairment of
peripheral endothelial function in IL-62/2 mice (Figure 3G)
excluding the presence of endothelial dysfunction in IL-62/2 mice
that could predispose them to impaired exercise performance.
Maintenance of endothelial function in IL-62/2 in the present
study was also evidenced by the levels of nitrosyl-hemoglobin
(NOHb) in red blood cells (reflecting NO availability in the
circulation) which were no different from WT control mice
(unpublished data). These findings stay in line with recent work of
Schrader et al. [23] suggesting that IL-6 deficiency is not linked to
endothelial dysfunction but, on the contrary, protects against
angiotensin II-induced impairment of NO-dependent vasodilation.
An interesting finding of the present study was that the IL-62/2
mice during running at sub-maximal velocities consumed system-
atically less oxygen than the WT mice (Figure 1G). This
phenomena, i.e. lower oxygen uptake in IL-62/2 mice compared
to WT mice during running at the same absolute running velocity
was originally reported by Fäldt et al. [7] (see Figure 4 therein).
However, these authors postulated that reduced oxygen consump-
tion during exercise causes a progressive oxygen depletion in these
animals, which impairs their ability to continue running [7].
Moreover, Fäldt et al. (2004) speculated that impaired heart
function and reduced capillarisation in the IL-62/2 mice could be
responsible for their poorer running capacity. In turn, our results
suggest that the poorer running capacity reported in the IL-62/2
mice was not caused by limited oxygen delivery. We have found
no differences in the V9O2max between the IL-6
2/2 and the WT
mice (see Figure 1D), indicating that the oxygen delivery to the
working muscles as well as its utilization during exercise was well
preserved in the IL-62/2 mice. Furthermore, lower V9O2
observed during subsequent steps of the incremental test (see
Figure 1E) and during running at 12 m.min21 (Figure 1F) was not
due to limitation in V9O2max in the IL-6
2/2 mice. Therefore, we
strongly suggest that lower oxygen uptake observed during sub-
maximal running in IL-62/2 is not a sign of a limited oxygen
delivery as suggested previously [7] but is related to the adaptive
mechanisms aimed to achieve enhanced mechanical efficiency in
IL-62/2 mice.
In order to understand the physiological background of this
mechanism, we measured some muscle proteins expression/
activities involved in oxygen cost of work including sarcoplasmic
reticulum Ca2+-ATPase1 (SERCA1), uncoupling protein-3 (UCP-
3) as well as COX and CS activities (for overview see [24–26]). We
have found lower expression of SERCA1 in soleus muscle in IL-62/
2 than in WT mice (Figure 5A). This could at least partly explain
the lower oxygen cost of running at sub-maximal running
velocities in the IL-62/2 mice (for overview see [24–26]). Lower
oxygen cost of the run in the IL-62/2 mice could be also due to
lower expression of UCP-3 in their locomotor muscles and lower
energy dissipation during exercise (see e.g. [27]). However, in the
present study we found no difference between UCP-3 expression
in the gastrocnemius muscle of the IL-62/2 mice when compared to
the WT mice (see Figure 5D). Accordingly, no change in basal and
post-running temperature was observed in IL-62/2 mice when
compared to the WT (see Figures 3C and 3D). On the other hand,
we found higher citrate synthase (CS) activity (considered as a
marker of mitochondria volume density - see e.g. [27,28]) in the
soleus muscle of the IL-62/2 mice when compared to the WT mice
(Figure 4C). However, the maximal COX activity measured in the
soleus muscle of IL-62/2 mice was not different when compared to
WT mice (see Figure 4A). Moreover, the maximal COX activities
measured in the gastrocnemious muscle of IL-62/2 mice and WT
mice were not significantly different (see Figure 4B). This suggest
that the oxidative phosphorylation activity of the soleus and the
gastrocnemius muscles in IL-62/2 mice and WT mice are similar.
Therefore, the lower oxygen cost of running observed in IL-62/2
mice cannot be explained by higher oxidative phosphorylation
activity in their locomotor muscles.
In contrast to humans, mice can successfully perform prolonged
endurance running close to their V9O2max (as observed during the
measurements of V9O2max in this study). This suggests that mouse
locomotor muscles possess greater abilities to tolerate metabolic
acidosis during endurance running. Little, however, is known
about the role of IL-6 in developing of metabolic acidosis during
prolonged high intensity running in mice. In the present work we
demonstrated that plasma lactate concentration measured imme-
diately after 1 h run at 8 m.min21 was significantly lower (by out
50% i.e. 5.260.3 vs. 10.160.3 mmol.l21) in IL-62/2 than in WT
mice. This is an original new finding showing lower lactatemia in
the IL-6-deficient mice while performing endurance run at the
same absolute running velocity (see, Figure 4E). This was
accompanied by lower oxygen cost of running at submaximal
running velocities in those mice (Figure 1G). Assuming that higher
plasma lactate concentration is accompanied by greater muscle
acidosis and lager disturbances in muscle metabolic stability
resulting in lower muscle mechanical efficiency (see [24,25,29]),
the observed lower oxygen cost of running in the IL-62/2 mice
Table 1. The blood count and plasma lipid profile of WT
control and IL-62/2 mice.
WT IL-62/2
WBC [K. ul21] 3.0361.33 3.2361.36
LYM% [%] 72.5610.7 77.7467.61
MON% [%] 5.160.91 4.5961.03
GRA% [%] 22.4610.14 17.6766.86
LYM [K.ul21] 2.1460.84 2.561.1
MON [K.ul21] 0.1260.08 0.2160.29
GRA [K.ul21] 0.8560.65 0.6360.31
RBC [M.ul21] 9.3560.76 9.7860.56
HGB [g.dl21] 13.1760.96 13.6260.53
HCT [%] 47.2164.22 48.4662.1
MCV [fl] 50.461.58 49.661.1
MCH [pg] 14.1260.51 13.9460.66
MCHC [g.dl21] 27.9661.41 28.1361.1
RDW [%] 13.7660.79 13.560.37
PLT [K.ul21] 1561.336223.44 1363.86198.31
MPV [fl] 5.3460.21 5.2160.1
LDL [mmol.l21] 0.097560.05 0.09260.27
HDL [mmol.l21] 0.8360.19 1.0260.27
TC [mmol.l21] 1.4960.29 1.77560.46
TG [mmol.l21] 0.4160.18 0.4960.26
WBC (white blood cells: LYM% (% of lymphocytes), MON% (% of monocytes),
GRA% (% of granulocytes)), RBC (red blood cells), HGB (hemoglobin), HCT
(hematocrit), MCV ((red cell) mean corpuscular volume), MCH ((red cell) mean
corpuscular hemoglobin), MCHC ((red cell) mean corpuscular hemoglobin
concentration), RDW (red cell distribution width), PLT (platelets), MPV (mean
platelets volume), LDL (low-density lipoprotein), HDL (high-density lipoprotein),
TC (total cholesterol), TG (triglicerydes). Data are presented as means 6 SEM.
doi:10.1371/journal.pone.0088333.t001
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Figure 4. Post-exercise plasma lactate and COX, CS activities in skeletal muscles in WT and IL-62/2 mice. COX and CS activities in soleus
(A, C) and gastrocnemius (B, D) skeletal muscles were measured in lysates from non-exercising WT control mice and IL-62/2 mice. Post-exercise
plasma lactate concentration (E) was assessed both in non-exercising mice (WT at rest and IL-62/2 at rest) as well as in animals subjected to single
bout of exercise (1-hour run at 8 m.min21). (F) Plasma lactate concentration at V9O2max during maximal incremental running test until exhaustion in
WT mice and IL-62/2 mice. Data are presented as the mean 6 SEM and symbols * denote values significantly different: **(P,0.01), ***(P,0.001).
Statistical analysis was performed in GraphPad Prism5 (two-sided T-test, n = 7–11).
doi:10.1371/journal.pone.0088333.g004
Figure 5. Skeletal muscle protein profile of WT and IL-62/2 mice. Whole-muscle soleus (A,B) and gastrocnemius (C,D) lysates were used to
assess the levels of sarcoplasmic reticulum Ca2+-ATPase 1 (SERCA1) and uncoupling protein 3 (UCP3). Values on the graphs represent means 6 SEM.
Representative Western Blot images acquired for the same membrane at the same exposure time are shown to compare protein levels between WT
and IL-62/2 mice with GAPDH used as the loading control for gastrocnemius. For soleus, we used Coomassie blue staining of protein gels as a loading
control (not shown). The symbol * denotes values significantly different from WT controls: *(P,0.05). Statistical analysis was performed in GraphPad
Prism5 (two-sided T-test, n = 7–8).
doi:10.1371/journal.pone.0088333.g005
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could be related to lesser disturbances in muscle metabolic stability
in their muscles during running at submaximal velocities when
compared to the WT mice. It should be noticed that during this
run (running at the same absolute running velocity amounting to
8 m.min21) the relative exercise intensity in case of IL-62/2 mice
was much higher than in case of WT mice due to above
mentioned lower maximal running capacity (by about 25%) found
in IL-62/2 mice (see Figure 1A) but still plasma lactate
concentration in IL-62/2 mice after this run was much lower
than in WT mice. This is, indeed, an interesting new finding
showing that IL62/2 mice, despite of running at relatively higher
running velocity, paradoxically accumulate much less lactate in
the blood than WT mice. Interestingly, in the present study we
have also demonstrated to our knowledge for the first time that the
maximal plasma lactate concentration after fatiguing run to
exhaustion in IL-62/2 mice was significantly lower than in WT
mice (see Figure 4F). Results collected in this study unable us to
explain the reason for lesser accumulation of plasma lactate in IL-
62/2 mice as compared to WT mice since lower plasma lactate
concentration in this case could be due to lower muscle lactate
production and/or faster lactate uptake by various cells (see e.g.
[30,31]). Nevertheless, our results clearly indicate that IL-6 is
strongly involved in the mechanism responsible for plasma lactate
accumulation during exercise both during sub-maximal and
maximal running velocities. In physiological conditions higher
plasma lactate concentration at a given power output is associated
with poorer performance of sustained exercise (see e.g. [32–34])
and, therefore, lower plasma lactate concentration in IL-62/2
mice should be associated with better tolerance of sustained
exercise. This could explain the preserved good endurance
capacity of the IL-62/2 mice during low intensity running when
compared to WT mice (see Figure 2A). On the other hand, low
plasma lactate concentration observed in IL-62/2 mice during run
at 8 m.min21 when compared to WT mice could result from
impaired anaerobic glycolysis as well as from faster glycogen
depletion during exercise. Both these factors could be responsible
for poorer running performance at high velocities found in this
study in IL-62/2 mice when compared to WT mice (see
Figures 1C and 2B). Regarding the maximal incremental exercise,
the lower plasma lactate concentrations found after this fatiguing
run in IL-62/2 mice when compared to WT mice (see Figure 4F)
suggest that IL62/2 mice possess poorer anaerobic glycolytic
energy capacity than WT mice. This could at least partly explain
their poorer maximal running capacity (near V9O2max). Interest-
ingly, it was recently reported that poorer endurance swimming
capacity of IL-62/2 mice was accompanied by greater intramus-
cular glycogen depletion after fatiguing exercise [8]. This is in
accordance with the findings by Kelly et al. (2009) [35] that IL-6
increases substrate availability within the muscle cell by increasing
glycogenolysis and lipolysis.
In the present study, we found no difference in glucose tolerance
between IL-62/2 mice and WT mice, which indicates that, at least
at rest, lack of IL-6 has no effect on glucose homeostasis. Our
results are in accordance with the findings by [36] that IL-6 is not
necessary for glucose production during non-exhaustive exercise.
It was also recently reported, in contrast to previous observations,
that IL-6 release in humans during exercise was not directly
correlated with the release or uptake of exogenous substrate, nor to
muscle glycogen utilization [37]. This suggests that more studies
are needed to establish the quantitative significance of IL-6 in the
carbohydrate metabolism during exercise in humans.
Conclusions
The present study confirmed the previous reports showing that
IL-62/2 mice displayed reduced exercise performance as
evidenced by lower maximal running velocity during maximal
incremental test and shorter time to exhaustion at running velocity
of 12 m.min21. We provided novel evidence suggesting that
poorer running capacity in IL-62/2 mice is not due to lower
V9O2max, impairment of peripheral endothelial function, glucose
intolerance or impaired muscle oxidative capacity. Therefore, our
results indicate that IL-6 cannot be regarded as a major regulator
of exercise capacity but rather as a modulator of high intensity
endurance performance. We also identified that IL-62/2 mice
displayed lower cost of running at a given sub-maximal running
velocity linked to the lower expression of SERCA1 in soleus muscle
and lesser plasma lactate accumulation during running at sub-
maximal and at maximal velocities. This response seems to
constitute an important compensatory mechanism limiting
reduced exercise performance in IL-62/2 mice.
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